(Q44068933)

29 November 2017

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. (English)

1 reference

29 November 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

Hisayuki Hamada

1

1 reference

29 November 2017

Hiroshi Yatsuhashi

2

1 reference

29 November 2017

Koji Yano

3

1 reference

29 November 2017

Manabu Daikoku

4

1 reference

29 November 2017

Kokichi Arisawa

5

1 reference

29 November 2017

Osami Inoue

6

1 reference

29 November 2017

Michiaki Koga

7

1 reference

29 November 2017

Keisuke Nakata

8

1 reference

29 November 2017

Katsumi Eguchi

9

1 reference

29 November 2017

Michitami Yano

10

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

95

1 reference

29 November 2017

2

1 reference

29 November 2017

331-339

1 reference

Natural history of hepatitis C: its impact on clinical management

29 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Natural history of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Which patients with hepatitis C develop liver complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Epidemiology and long term prognosis of hepatitis C virus infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Mechanisms and implications of the age-associated decrease in DNA repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

7 January 2021

Natural history of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

7 January 2021

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

7 January 2021

Management of cancer in the older person: a practical approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10662

7 January 2021

Identifiers

DOI

10.1002/CNCR.10662

1 reference

29 November 2017

1 reference